The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...
Treatment with a 1726-nm laser resulted in sustained efficacy for moderate-to-severe acne, with more than 90% of treated patients achieving at least a 50% reduction in inflammatory lesions at 52 weeks ...